Means Investment Company’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$239K Sell
8,500
-5,600
-40% -$149K 0.02% 179
2025
Q4
$1.2K Buy
+14,100
New +$356K ﹤0.01% 186

Other funds holding PFE

Means Investment Company's PFE Position: Q1 2026 in Review

Means Investment Company increased its Pfizer (PFE) stake by 0.96% in Q1 2026, buying an estimated $3.3K and bringing the position to 13,058 shares worth $367K. The position accounts for 0.03% of the portfolio, ranked #147.

Means Investment Company first reported a position in PFE in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.49M in Q4 2021. 2,946 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Means Investment Company held 13,058 shares of Pfizer worth $367K as of Q1 2026.
  • Means Investment Company bought 124 Pfizer shares in Q1 2026, an estimated $3.3K.
  • Pfizer made up 0.03% of Means Investment Company's portfolio in Q1 2026, its #147 holding.
  • Means Investment Company first reported a position in Pfizer in Q4 2018 and has held it in 30 quarters since.
  • Means Investment Company's Pfizer position peaked at $2.49M in Q4 2021.
  • 2,946 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Means Investment Company's 13F filing for Q1 2026, filed 24 Apr 2026.